Chris Guiffre is the founder of Pear Therapeutics. Pear Therapeutics has raised $250M in total funding. Latest round: Series D. Backed by SoftBank.
Chris Guiffre was the CEO of Pear Therapeutics, a company that developed prescription digital therapeutics. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023. Prior to this, Guiffre was appointed as the Chief Financial Officer of NodThera in October 2025, a clinical-stage biotech focused on treating chronic inflammatory diseases. He has over 25 years of executive experience in life science and tech companies.
Full founder directory · Investor directory · Company funding database · Fundraising library